Further mechanistic studies, such as those involving the administration of exogenous IL-37 (e.g., recombinant human IL-37 or IL-37 transgenic mice), are necessary to elucidate the precise role of IL-37 in atherosclerosis. The gene discussed is IL37; the disease is atherosclerosis.